(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) slid 5.29% to $5.91 at 11:10 EST on Tuesday, following the last session’s upward trend. NASDAQ is dropping 1.36% to $14,691.13, following the last session’s upward trend. This seems, at the moment, an all-around negative trend trading session today.

Catalyst Pharmaceuticals’s last close was $6.24, 17.68% under its 52-week high of $7.58.


Today’s last reported volume for Catalyst Pharmaceuticals is 241875 which is 74.43% below its average volume of 946104.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the present quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.75%, a negative 0.39%, and a positive 2.14%, respectively.

Catalyst Pharmaceuticals’s highest amplitude of average volatility was 1.84% (last week), 1.93% (last month), and 2.14% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $5.91 at 11:10 EST, way below its 52-week high of $7.58 and way higher than its 52-week low of $3.27.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is below its 50-day moving average of $6.53 and above its 200-day moving average of $5.51.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here